Search results
Found 37950 matches for
A Phase III study of the Oxford-AstraZeneca coronavirus vaccine conducted by AstraZeneca plc in the USA, Chile and Peru has shown that vaccine is safe and highly effective, adding to previous trial data from the United Kingdom, Brazil and South Africa, as well as real-world impact data from the United Kingdom.
Rose McGready
Principal Investigators
Rose McGready - Professor of Tropical Maternal and Child Health
Peijun Zhang
Principal Investigators
Peijun Zhang - Professor of Structural Biology and WELLCOME TRUST INVESTIGATOR
Joel Tarning
MSc MGH Lecturers Principal Investigators
Joel Tarning - Professor of Clinical Pharmacology
Louise Thwaites
Clinical Consultants Principal Investigators
BSc MBBS MRCP MD DMSMed MLCOM Louise Thwaites - Associate Professor
Peter Ratcliffe
Clinical Consultants Principal Investigators
FRS Peter Ratcliffe - Professor of Clinical Medicine
Anita Milicic
Principal Investigators
Associate Professor Anita Milicic - Group Leader, Vaccine Formulation and Adjuvants
Catherine (Sassy) Molyneux
Principal Investigators
Catherine (Sassy) Molyneux - Professor of Global Health
Peter Horby
Clinical Consultants Principal Investigators
FMedSci Peter Horby - Moh Family Foundation Professor of Emerging Infections and Global Health